Renew Biopharma Inc is a research company developing proprietary therapeutics to treat neurodegenerative diseases, traumatic brain injuries (TBI), and for pain management. CEO Mike Mendez provides an introduction to the company and explains its interest in developing treatments using biosynthetic cannabinoids.
SAN FRANCISCO -- (BUSINESS WIRE) -- Michael Mendez, Renew Biopharma founder and CEO, and long-time biotech industry pioneer, will speak tomorrow about his company’s quest to look beyond the Cannabis plant to discover and develop “a new world of novel therapeutics” at SynBioBeta 2018.
NBC Bay Area 2 Part Series: Perhaps the biggest threat to contact sports, particularly football, is concussions. They’re ending careers early and leaving countless players with permanent brain damage.
But new research in California suggests there could be a cure on the horizon.